Anidulafungin

This classification denotes an antifungal agent with the molecular formula C58H73N7O17, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9HLM53094I, chemically known as echinocandin b, 1-((4r,5r)-4,5-dihydroxy-n2-((4-(pentyloxy)(1,1:4,1-terphenyl)-4-yl)carbonyl)-l-ornithine) but generally known as anidulafungin, which bears US NIH Compound Identifier 166548. European Medicines Agency schedules Anidulafungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22240. The term ANIDULAFUNGIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules anidulafungin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule anidulafungin under HS 29419000 and SITC 54139. As of Q4 2014, ANIDULAFUNGIN remains the US FDA Preferred Term for this commodity. Anidulafungin bears US NLM identifiers UMLS ID C1142738 and NCI Concept Code C38716. SMILES: OC1C(CN2C1C(=O)NC(O)C(O)CC(NC(=O)C1CCC(CC1)C1CCC(CC1)C1CCC(OCCCCC)CC1)C(=O)NC(C(=O)N1C(CC(O)C1)C(=O)NC(C(=O)NC(C2=O)C(O)C)C(O)C(O)C1CCC(O)CC1)C(O)C)C.